532959-63-0

Upstream product

• 960254-05-1 N-[4-(5-amino-4-cyano-2-ethyl-1H-imidazol-1-yl)butyl]methanesulfonamide 
• 723282-40-4 N-4-(4-aminobutyl)methanesulfonamide hydrochloride 
• 960254-09-5 N-{4-[5-(2-aminophenyl)-4-cyano-2-ethyl-1H-imidazol-1-yl]butyl}methanesulfonamide 

Relevant academic research and scientific papers

Ring Closing and Related Methods and Intermediates

Methods and intermediates useful for making compounds of the formula: and the preparation of compounds of Formula I, preferably including the formation of intermediate compounds of the formula:

METHOD FOR 1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF

Methods and intermediates for preparing compounds of the Formulas: (I and X) are disclosed. The methods include a method providing a compound of the Formula: (IV) and converting a compound of Formula IV to a compound of Formula I, a method providing a compound of the Formula: (VIII) and converting a compound of Formula VIII to a compound of Formula I, and a method providing a compound of the Formula: (XI) and converting a compound of Formula XI to a compound of Formula I.

SULFONAMIDE SUBSTITUTED IMIDAZOQUINOLINES

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines an

Sulfonamide and sulfamide substituted imidazoquinolines

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain sulfonamide or sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of vario